다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

IOBT

IO Biotech (IOBT)

IO Biotech Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:IOBT

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/14	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/05/14	21:13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
2024/05/14	20:55	GlobeNewswire Inc.	IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights	NASDAQ:IOBT	IO Biotech Inc
2024/04/25	05:30	GlobeNewswire Inc.	IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2024/04/15	21:30	GlobeNewswire Inc.	IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness	NASDAQ:IOBT	IO Biotech Inc
2024/04/10	01:00	GlobeNewswire Inc.	IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103	NASDAQ:IOBT	IO Biotech Inc
2024/04/05	21:30	GlobeNewswire Inc.	IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer	NASDAQ:IOBT	IO Biotech Inc
2024/03/12	05:56	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IOBT	IO Biotech Inc
2024/03/07	06:11	GlobeNewswire Inc.	IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	07:17	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	06:46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	06:40	GlobeNewswire Inc.	IO Biotech Announces 2023 Fourth-Quarter and Year-End Results	NASDAQ:IOBT	IO Biotech Inc
2024/02/27	06:05	GlobeNewswire Inc.	IO Biotech to Present at 44th Annual Cowen Health Care Conference	NASDAQ:IOBT	IO Biotech Inc
2024/01/08	22:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2023/12/21	22:30	GlobeNewswire Inc.	IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial	NASDAQ:IOBT	IO Biotech Inc
2023/11/25	07:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOBT	IO Biotech Inc
2023/11/14	06:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
2023/11/13	22:12	GlobeNewswire Inc.	IO Biotech Announces 2023 Third Quarter Results	NASDAQ:IOBT	IO Biotech Inc
2023/11/13	22:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2023/11/13	22:00	GlobeNewswire Inc.	IO Biotech Appoints Helen Collins, MD, to its Board of Directors	NASDAQ:IOBT	IO Biotech Inc
2023/11/10	22:00	GlobeNewswire Inc.	IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma	NASDAQ:IOBT	IO Biotech Inc
2023/11/09	06:30	GlobeNewswire Inc.	IO Biotech Announces Participation in Upcoming Investor Conferences	NASDAQ:IOBT	IO Biotech Inc
2023/11/01	21:30	GlobeNewswire Inc.	IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2023/10/23	14:00	GlobeNewswire Inc.	Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Socie	NASDAQ:IOBT	IO Biotech Inc
2023/10/04	05:30	GlobeNewswire Inc.	IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2023/09/13	05:06	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NASDAQ:IOBT	IO Biotech Inc
2023/09/12	21:05	GlobeNewswire Inc.	IO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancer	NASDAQ:IOBT	IO Biotech Inc
2023/09/11	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:IOBT	IO Biotech Inc
2023/09/07	23:36	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:IOBT	IO Biotech Inc
2023/09/06	21:35	GlobeNewswire Inc.	IO Biotech Announces Participation in Upcoming Investor Conferences	NASDAQ:IOBT	IO Biotech Inc

검색 관련기사 보기:NASDAQ:IOBT

1 2 3 4 다음 >>

BMO Covered Call Energy ...

Deutsche Lufthansa

Basic Attention Token

Global X Genomics & Biot...

Bioblast Pharma Ltd.

Vontobel Financial Produ...

AMUNDI JAPAN TOPIX UCITS...

Nauticus Robotics

Societe Generale SFH Eo-...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관